“…This was a weakness of LC-MS analysis, and LC-MS was limited to the analysis of hydrophobic metabolites such as lipids. However, the development of column technology enabled the retention and separation of hydrophilic metabolites (Alpert, 1990;Yoshida et al, 2007). This technology has been applied for the research of drug metabolites (Plumb et al, 2003), galactosamine toxicity (Spagou et al, 2011), and renal cell carcinoma diagnosis, staging, and biomarker discovery (Lin et al, 2011a).…”